Blue Trust Inc. Has $106,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Blue Trust Inc. lessened its position in iShares Biotechnology ETF (NASDAQ:IBBFree Report) by 20.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 782 shares of the financial services provider’s stock after selling 201 shares during the period. Blue Trust Inc.’s holdings in iShares Biotechnology ETF were worth $106,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Jacobi Capital Management LLC boosted its stake in shares of iShares Biotechnology ETF by 3.7% in the 3rd quarter. Jacobi Capital Management LLC now owns 2,539 shares of the financial services provider’s stock valued at $310,000 after purchasing an additional 91 shares in the last quarter. Geneos Wealth Management Inc. lifted its position in iShares Biotechnology ETF by 16.7% during the 3rd quarter. Geneos Wealth Management Inc. now owns 644 shares of the financial services provider’s stock worth $79,000 after buying an additional 92 shares in the last quarter. PFG Investments LLC lifted its position in iShares Biotechnology ETF by 4.8% during the 3rd quarter. PFG Investments LLC now owns 2,013 shares of the financial services provider’s stock worth $246,000 after buying an additional 93 shares in the last quarter. Huntington National Bank lifted its position in iShares Biotechnology ETF by 7.4% during the 3rd quarter. Huntington National Bank now owns 1,450 shares of the financial services provider’s stock worth $177,000 after buying an additional 100 shares in the last quarter. Finally, Sovereign Financial Group Inc. lifted its position in iShares Biotechnology ETF by 1.5% during the 4th quarter. Sovereign Financial Group Inc. now owns 6,861 shares of the financial services provider’s stock worth $901,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.3 %

Shares of NASDAQ IBB opened at $133.53 on Thursday. The firm’s 50-day simple moving average is $136.47 and its 200 day simple moving average is $129.05. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Investors of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 annualized dividend and a yield of 0.38%.

iShares Biotechnology ETF Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.